IC
IBIO icon

IEQ Capital’s iBio IBIO Stock Holding History

IEQ Capital’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$56K – 395
2020
Q2 		$56K Buy
+50
New +$32.7K ﹤0.01% 314

Other funds holding IBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

IEQ Capital's IBIO Position: Q3 2020 in Review

IEQ Capital sold out of iBio (IBIO) in Q3 2020, closing a stake of 50 shares — an estimated $56K sold.

IEQ Capital first reported a position in IBIO in Q2 2020 and held it in 1 quarter. The position peaked at $56K in Q2 2020. 77 funds tracked by Wall St. Rank hold IBIO as of Q3 2020.

  • IEQ Capital reported no remaining iBio position as of Q3 2020 after selling out during the quarter.
  • IEQ Capital sold 50 iBio shares in Q3 2020, an estimated $56K.
  • IEQ Capital first reported a position in iBio in Q2 2020 and held it in 1 quarter.
  • IEQ Capital's iBio position peaked at $56K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held iBio as of Q3 2020.

Based on IEQ Capital's 13F filing for Q3 2020, filed 3 Nov 2020.